OBJECTIVE: To estimate the potential health impact and cost-effectiveness of nationwide Haemophilus influenzae type b (Hib) vaccination in India. STUDY DESIGN: A decision support model was used, bringing together estimates of demography, epidemiology, Hib vaccine effectiveness, Hib vaccine costs, and health care costs. Scenarios favorable and unfavorable to the vaccine were evaluated. State-level analyses indicate where the vaccine might have the greatest impact and value. RESULTS: Between 2012 and 2031, Hib conjugate vaccination is estimated to prevent over 200 000 child deaths (∼1% of deaths in children <5 years of age) in India at an incremental cost of US$127 million per year. From a government perspective, state-level cost-effectivenes...
BACKGROUND: In concert with efforts to increase global provision, economic evaluations of newer and ...
Background Haemophilus influenzae type B (Hib) causes significant morbidity and mortality in childre...
Haemophilus influenzae type b (Hib) conjugate vaccine is a safe and effective vaccine that can preve...
ObjectiveTo estimate the potential health impact and cost-effectiveness of nationwide Haemophilus in...
OBJECTIVES: To estimate the cost-effectiveness of Haemophilus influenzae type b (Hib) conjugate vacc...
OBJECTIVE: Haemophilus influenzae type b (Hib) vaccine was introduced into routine immunization serv...
OBJECTIVE: Haemophilus influenzae type b (Hib) vaccine was introduced into routine immunization serv...
ObjectivesTo estimate the cost-effectiveness of Haemophilus influenzae type b (Hib) conjugate vaccin...
Haemophilus influenzae type b (Hib) is an infectious bacterium transmitted from person to person thr...
BACKGROUND: Most of Asia, including Indonesia, does not use Haemophilus influenzae type b (Hib) conj...
Background: Most of Asia, including Indonesia, does not use Haemophilus influenzae type b (Hib) conj...
BACKGROUND: With GAVI support, Vietnam introduced Haemophilus influenzae type b (Hib) vaccine in 201...
Background/Aims: Most countries with high hepatitis B (HB) virus endemicity and most high-income cou...
<p><b>Aims:</b> The World Health Organization (WHO) recommends the use of <i>Haemophilus influenzae<...
Pneumococcal pneumonia causes an estimated 105,000 child deaths in India annually. The planned intro...
BACKGROUND: In concert with efforts to increase global provision, economic evaluations of newer and ...
Background Haemophilus influenzae type B (Hib) causes significant morbidity and mortality in childre...
Haemophilus influenzae type b (Hib) conjugate vaccine is a safe and effective vaccine that can preve...
ObjectiveTo estimate the potential health impact and cost-effectiveness of nationwide Haemophilus in...
OBJECTIVES: To estimate the cost-effectiveness of Haemophilus influenzae type b (Hib) conjugate vacc...
OBJECTIVE: Haemophilus influenzae type b (Hib) vaccine was introduced into routine immunization serv...
OBJECTIVE: Haemophilus influenzae type b (Hib) vaccine was introduced into routine immunization serv...
ObjectivesTo estimate the cost-effectiveness of Haemophilus influenzae type b (Hib) conjugate vaccin...
Haemophilus influenzae type b (Hib) is an infectious bacterium transmitted from person to person thr...
BACKGROUND: Most of Asia, including Indonesia, does not use Haemophilus influenzae type b (Hib) conj...
Background: Most of Asia, including Indonesia, does not use Haemophilus influenzae type b (Hib) conj...
BACKGROUND: With GAVI support, Vietnam introduced Haemophilus influenzae type b (Hib) vaccine in 201...
Background/Aims: Most countries with high hepatitis B (HB) virus endemicity and most high-income cou...
<p><b>Aims:</b> The World Health Organization (WHO) recommends the use of <i>Haemophilus influenzae<...
Pneumococcal pneumonia causes an estimated 105,000 child deaths in India annually. The planned intro...
BACKGROUND: In concert with efforts to increase global provision, economic evaluations of newer and ...
Background Haemophilus influenzae type B (Hib) causes significant morbidity and mortality in childre...
Haemophilus influenzae type b (Hib) conjugate vaccine is a safe and effective vaccine that can preve...